Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 2,795 | 2,105 | 2,965 | 6,666 | 1,385 |
| Operating Income | -2,795 | -2,105 | -2,965 | -6,666 | -1,385 |
| Other Income | -11 | -5 | -5 | 4 | 11 |
| Pre-tax Income | -2,806 | -2,110 | -2,970 | -6,662 | -1,374 |
| Net Income Continuous | -2,806 | -2,110 | -2,970 | -6,662 | -1,374 |
| Net Income | $-2,806 | $-2,110 | $-2,970 | $-6,662 | $-1,374 |
| EPS Basic Total Ops | -6.47 | 0.72 | -7.73 | -23.74 | -10.61 |
| EPS Basic Continuous Ops | -6.51 | 45.80 | -7.69 | -28.84 | -59.69 |
| EPS Diluted Total Ops | -6.47 | 0.72 | -7.73 | -23.74 | -10.61 |
| EPS Diluted Continuous Ops | -6.51 | 45.80 | -7.69 | -28.84 | -59.69 |
| EBITDA(a) | $-2,792 | $-2,101 | $-2,963 | $-6,654 | $-1,381 |